Anzeige
Mehr »
Freitag, 07.08.2026 - Börsentäglich über 12.000 News
SalesCloser Technologies: Facebook, YouTube, Instagram, WhatsApp oder TikTok!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41YV4 | ISIN: US2939048011 | Ticker-Symbol:
1-Jahres-Chart
VISKASE HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
VISKASE HOLDINGS INC 5-Tage-Chart

Aktuelle News zur VISKASE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoViskase Holdings, Inc. - 10-Q, Quarterly Report1
05.05.Viskase Holdings, Inc. - 8-K, Current Report1
04.05.Viskase Holdings, Inc. - 10-Q, Quarterly Report9
VISKASE Aktie jetzt für 0€ handeln
15.04.Viskase Holdings, Inc. - 8-K, Current Report-
26.03.Viskase Holdings, Inc. - 8-K, Current Report3
25.03.Enzon Pharmaceuticals, Inc: Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock13
24.03.Enzon Pharmaceuticals executes 1-for-100 reverse stock split ahead of merger12
24.03.Enzon Pharmaceuticals, Inc: Enzon Announces Reverse Stock Split545CRANFORD, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) ("Enzon" or the "Company"), today announced that the previously approved 1-for-100 reverse stock split...
► Artikel lesen
24.03.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report2
16.03.Enzon Pharmaceuticals, Inc: Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock1
16.03.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report-
09.03.Enzon Pharmaceuticals, Inc: Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock4
09.03.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
02.03.ENZON PHARMACEUTICALS, INC. - 10-K, Annual Report-
27.02.Enzon Pharmaceuticals, Inc: Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock2
27.02.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
11.02.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
30.01.Enzon Pharmaceuticals, Inc: Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger242CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) ("Enzon" or the "Company"), today announced that it has commenced an exchange offer (the "Offer") involving...
► Artikel lesen
24.10.25Enzon Pharmaceuticals, Inc: Enzon and Viskase Announce Amendment to Merger Agreement469CRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) ("Enzon" or the "Company") and Viskase Companies, Inc. (OTC Pink Limited: VKSC) ("Viskase")...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1